Crossmark

Investigation of 1H-1,2,3-triazole derivatives as TGF-β pathway targeted therapeutics for oral squamous cell carcinoma: an in-silico approach

Published Online: 2026-09-11

Authors

Mal, Sadananda https://orcid.org/0009-0003-7617-4365
Das, Raunak Kumar https://orcid.org/0000-0003-1293-3425
Funding

Funding for this research was provided by:

Vellore Institute of Technology, Vellore
License Information

Text and Data Mining valid from 2026-09-11

Accepted Manuscript valid from 2026-09-11
More Information

Article History

Received: 13 February 2026

Accepted: 26 August 2026

First Online: 11 September 2026

Ethics

Competing interests: The authors declare no competing interests.

Document is current